Whittier Trust Co. of Nevada Inc. Reduces Stake in Sanofi (NASDAQ:SNY)

Whittier Trust Co. of Nevada Inc. lowered its position in Sanofi (NASDAQ:SNY) by 39.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,094 shares of the company’s stock after selling 1,369 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in Sanofi were worth $102,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in SNY. Rise Advisors LLC lifted its stake in Sanofi by 98.4% in the fourth quarter. Rise Advisors LLC now owns 506 shares of the company’s stock worth $25,000 after purchasing an additional 251 shares during the last quarter. Salem Investment Counselors Inc. bought a new stake in shares of Sanofi during the fourth quarter valued at approximately $27,000. Venturi Wealth Management LLC raised its stake in shares of Sanofi by 163.5% during the fourth quarter. Venturi Wealth Management LLC now owns 535 shares of the company’s stock valued at $27,000 after acquiring an additional 332 shares in the last quarter. Frazier Financial Advisors LLC bought a new stake in shares of Sanofi during the fourth quarter valued at approximately $28,000. Finally, Register Financial Advisors LLC bought a new stake in shares of Sanofi during the first quarter valued at approximately $29,000. Institutional investors own 10.04% of the company’s stock.

Sanofi Stock Down 0.3 %

SNY stock traded down $0.17 during trading on Tuesday, hitting $50.07. 3,091,410 shares of the company’s stock traded hands, compared to its average volume of 2,137,456. The firm has a market capitalization of $126.81 billion, a P/E ratio of 25.25, a PEG ratio of 1.54 and a beta of 0.59. The business has a fifty day simple moving average of $48.77 and a two-hundred day simple moving average of $48.60. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.19. Sanofi has a 1 year low of $42.63 and a 1 year high of $55.72.

Sanofi (NASDAQ:SNY) last released its quarterly earnings results on Thursday, April 25th. The company reported $0.96 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.96. Sanofi had a net margin of 10.52% and a return on equity of 26.25%. The business had revenue of $11.36 billion for the quarter, compared to analyst estimates of $11.75 billion. Sell-side analysts anticipate that Sanofi will post 4.14 EPS for the current year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.